Voice outcome after unilateral ELS type III or bilateral type II resections for T1-T2 glottic carcinoma: Results after 1 year by Loon, Y. (Yda) van et al.
OR I G I NA L ART I C L E
Voice outcome after unilateral ELS type III or bilateral type II
resections for T1-T2 glottic carcinoma: Results after 1 year
Yda van Loon MD, MSc1 | Martine Hendriksma MD1 | Bas J. Heijnen SLP, MSc, PhD1 |
Vivienne A. H. van de Kamp SLP1 | Marieke M. Hakkesteegt PhD2 | Stefan Böhringer MD, PhD3 |
Ton P. M. Langeveld MD, PhD1 | M. A. de Jong MD, PhD4 | W. Martin C. Klop MD, PhD5 |
Robert J. Baatenburg de Jong MD, PhD2 | Elisabeth V. Sjögren MD, PhD1
1Department of Otorhinolaryngology, Head &
Neck Surgery, Leiden University Medical Center,
Leiden, The Netherlands
2Department of Otorhinolaryngology, Head &
Neck Surgery, Erasmus MC Cancer Institute,
Rotterdam, The Netherlands
3Department of Biomedical Data Sciences, Leiden
University Medical Center, Leiden, The
Netherlands
4Department of Radiotherapy, Leiden University
Medical Center, Leiden, The Netherlands
5Department of Head and Neck Surgery,
Netherlands Cancer Institute/Antoni van
Leeuwenhoek, Amsterdam, The Netherlands
Correspondence
Yda van Loon, Department of ENT, Head and
Neck Surgery H5-Q, Leiden University Medical
Center, Albinusdreef 2, Postbus 9600, 2300 RC
Leiden, The Netherlands.
Email: y.van_loon@lumc.nl
Funding information
ZOLEON, Stichting Oncologie Haaglanden West,
Leiden, the Netherlands
Abstract
Background: Voice outcome was assessed in patients with extended T1 and lim-
ited T2 glottic carcinoma, treated with a unilateral type III or a bilateral type II re-
section according to the European Laryngological Society (ELS) classification.
Methods: Objective evaluation (acoustic and aerodynamic parameters), perceptual
evaluation (GRBAS), and patients' self-assessment (voice handicap index [VHI])
were performed before and 1 year after treatment. Results were evaluated accord-
ing to ELS resection type and the involvement of the anterior commissure.
Results: The majority of voice parameters in all resection subgroups showed an
improvement of the mean score 1 year postoperatively. Grade of dysphonia varied
between 1.15 and 1.66 postoperatively and VHI score varied from 23.3 to 24.5.
Conclusion: Voice outcome after ELS unilateral type III or a bilateral type II re-
section for extended T1 and limited T2 glottic carcinoma is good with mild to very
moderate perceptive dysphonia and low self-reported voice impairment.
KEYWORDS
anterior commissure involvement, early glottic cancer, laser surgery, TLM, voice
outcome
1 | INTRODUCTION
The two main treatment modalities for early glottic carcinoma
(Tis-T2) are transoral CO2 laser microsurgery (TLM) and
radiotherapy (RT). There is no randomized study that proves
that one treatment modality is more effective than the other and
both are still widely used.1 However, several studies indicate
that although both treatments show similar local tumor control,
TLM as a primary treatment modality is associated with a
higher laryngeal preservation rate than RT2–5 as TLM leaves
all treatment options open in the case of recurrent disease.
In addition to oncological outcome, functional out-
come—mainly voice outcome—is an important factor when
choosing a primary treatment for these patients. It has been
shown that the postoperative voice outcome in limited resec-
tions such as subepithelial and subligamental resections
(type I-II according to the European Laryngological Society
[ELS] classification6) is normal or near to normal7,8 and that
voice outcome for TLM and RT in these lesions is
comparable.2,7,9–11 However, the postoperative voice is gen-
erally poorer in more extended resections (type III-IV) than
in superficial resections (type I-II).12–18 This is consistent
with greater glottal insufficiency due to tissue loss.12,13Yda van Loon and Martine Hendriksma contributed equally to this study.
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Moreover, when the tumor extends to the anterior commis-
sure (AC), poorer voice outcome is seen, regardless of the
treatment modality.16,19,20 When treated with TLM, the best
voice results are achieved when the AC can be left intact
along with part of the vocal fold muscle.21
Although the use of TLM is expanding, there is relatively
little data investigating voice outcome after more extensive uni-
lateral resections (type III-VI) or bilateral resections and no data
on the comparative outcome for RT in these larger lesions. This
is one of the reasons that the “Dutch guideline for the Treat-
ment of Laryngeal Carcinoma” considers TLM as the preferred
treatment only for superficial T1a midcord lesions, which are
resectable with a subepithelial or subligamental resection (type
I or II), with RT being the recommended treatment in more
extended T1 and T2 glottic lesions.22
Therefore, the aim of this study was to investigate voice
outcome in patients with early glottic carcinoma with an
extended T1 or limited T2 lesion requiring a unilateral trans-
muscular resection or a bilateral subligamental resection. If
functionally acceptable results can be achieved in our set-
ting, these resections can then be considered for routine
treatment of extended T1 and limited T2 glottic carcinoma.
This would be an addition to the unilateral subepithelial and
subligamental resections already performed in the Nether-
lands, giving these patients the benefit of additional treat-
ment options in the case of a recurrence.
2 | MATERIAL AND METHODS
2.1 | Patients
From December 2009 to March 2015, a non-randomized
multicenter prospective outcome study on functional out-
come after treatment for early glottic carcinoma (extended
T1N0 and limited T2N0) was started in three Dutch tertiary
referral hospitals (University Cancer Center Leiden - The
Hague, Erasmus Medical Center Cancer Institute, and Neth-
erlands Cancer Institute/Antoni van Leeuwenhoek). The tar-
get population of the study was patients with extended T1N0
and limited T2N0 glottic tumors that if treated surgically
would require a unilateral transmuscular resection—defined
as a type III cordectomy according to the ELS classification
or a bilateral subligamental resection which is does not have
an official ELS classification but would be best described as
a bilateral type II. To clarify these bilateral type II resections,
they consisted of subligamental resections on both sides of
the vocal cord including the AC, leaving the muscle and its
anterior attachment to the perichondrium intact. Some of the
resections were staged to prevent web formation. Prelimi-
nary inclusion in the study took place in the outpatient
clinics. All patients with a lesion possibly fitting the above
criteria were offered the choice between TLM or RT after
counseling, which was supplemented by written information
on the study treatments.23 Definite inclusion in the study
occurred during endoscopy for patients confirmed at that time
to have lesions fitting the inclusion criteria. Patients were then
treated according to their preference. Of the eligible patients,
only four (6.3%) chose RT. Due to the differences in group
size between TLM and RT, contrary to initial study plans,
patients who were treated with RT were not included in this
study. Total and extended cordectomies (type IV-VI) were also
excluded as they are currently viewed as too aggressive for
functional reasons for primary treatment of early glottic carci-
noma in the Netherlands and are therefore not performed on a
routine basis. Other exclusion criteria were the inability to
speak and read the Dutch language, preexistent problems with
the voice or swallowing, previous radiation for head and neck
tumor(s), and the presence of any psychological, familial,
sociological, or geographical condition potentially hampering
compliance with the study protocol or follow-up schedule.
Also patients who had recurrent disease in the first year after
treatment were excluded because the recurrence and the subse-
quent treatment were of potential influence on the functional
outcomes. In the study protocol, in case of positive margins a
second surgery could be carried out, and in case of bilateral
spread, the procedure could be staged. Voice outcome of
patients who participated in the study was investigated before
treatment and 1 year after treatment. During both visits, speech
was recorded and a self-administrated questionnaire, as
described below, was filled in. The study was approved by the
local medical ethics committees at all three hospitals and writ-
ten informed consent was obtained from all patients before
inclusion in the study.
2.2 | Subjective evaluation
2.2.1 | Perceptual voice evaluation
The perceptual analysis was performed on a running speech
voice sample, using the GRBAS-rating scale.24 This rating
consists of five domains: grade (G), roughness (R), breathiness
(B), asthenia (A), and strain (S). Only the grade (henceforth
G-score) was rated. A panel of five experienced listeners (E.V.
S., V.A.H. vdK., B.J.H., M.M.H, and Y.vL.) familiar with the
GRBAS-system, who were blinded to all data, conducted the
voice evaluation. Speech material for the perceptual analysis
consisted of a standard phonetically balanced Dutch text “80
dappere fietsers” (80 brave cyclists). Speech samples, with an
average duration of 30 seconds, were presented in a random
sequence, before or after treatment, and all samples were rated
by consensus. If the listeners scored the sample differently,
consensus was reached through reevaluation and discussion.
The outcome of each sample was classified from 0 to
3 (0 = normal; 1 = mild; 2 = moderate; and 3 = severe): a
higher score represents a more dysphonic voice.24
2.2.2 | Patient-self assessment
A patient self-report on the voice impact was completed by the
patients during their visits to the outpatient clinic by scoring the
voice handicap index (VHI).25 The Dutch version of the VHI is
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a validated questionnaire measuring the voice impairment in
daily life.26 The questionnaire comprises 30 questions on a
5-point Likert scale, with grading from 0 to 4 (0 = never and
4 = always). A total of 15 points or more out of a possible
120 points is taken to indicate voice impairment in daily life.27
A higher score represents a worse voice handicap. A clinically
relevant change is defined as a 10-point shift for individuals
and as a 15-point shift for groups.28 The VHI scores were also
categorized into five different groups: a score of 0 (normal
voice), scores of 1 to 30 (slight voice impairment), scores of
31 to 60 (moderate voice impairment), scores of 61 to
90 (severe voice impairment), and scores from 91 to 120 (very
severe voice impairment).13
2.3 | Objective evaluation
Recordings were made at a sampling frequency of 44.1 kHz
with a dual microphone headset recorder from Alphatron
Medical Systems recorder and with a Beyer dynamic micro-
phone, type Opus 56, Germany, in a noise-free environment.
Intensity and frequency measurements in a phonetogram
were obtained with an automatically recording Voice Pro-
filer (VRP) (2007, Alphatron, Rotterdam, the Netherlands).
Acoustic parameters (mean speaking fundamental frequency
in Hertz [Hz] and range Sound Pressure Level [SPL] in deci-
bel [dB]) were analyzed using the program VRP. The aero-
dynamic parameter (s/z ratio) was analyzed using the
program Audacity (Boston, Massachusetts). For the s/z ratio,
the longest waveform of each patient was recorded as their
/s/ or /z/. The duration of the /s/ sound was divided by the
duration of the /z/ sound, resulting in the s/z ratio.29 All
patients were instructed in vocal hygiene directly after sur-
gery. If patients asked for guidance or speech therapy was
indicated, they were referred to a speech-language patholo-
gist; however, this was not included in the protocol and not
standardized. Patients did not receive any speech therapy
before 3 months after TLM.
2.4 | Statistical methods
All statistical analyses were performed with SPSS version
23.0 (IBM Corp, Armonk, New York) and R version 3.4.0
(Foundation for Statistical Computing, Vienna, Austria).
The level of significance was set at P < .05. Normal distri-
bution assumptions were checked with the Kolmogorov-
Smirnov test and by computing skewness and kurtosis. Out-
come variables in this study were G-score, VHI, fundamen-
tal frequency, range SPL, and s/z ratio.
The effect of time on outcomes variables was assessed
with a paired t test to compare preoperative and postoperative
data in each patient. Additionally, we performed a linear
mixed model analysis with a random intercept for each patient
while adjusting for possible confounders: age, sex, and T clas-
sification. The preoperative and postoperative results between
the subgroups on all outcome variables (unilateral type III vs
bilateral type II and unilateral/bilateral resections with/without
involvement of the AC) were also compared with an indepen-
dent t test or with one-way analysis of variance.
To account for missing data, multiple imputation ana-
lyses were performed using package mice in R.30 Missing-
ness varied between 1% (preoperative s/z ratio) and 27%
(fundamental frequency) and therefore 30 imputed data sets
were generated. Imputation variables were all outcome vari-
ables and covariates used in the mixed models. Sensitivity
analysis was carried out by comparison with the complete
case analysis. Results from the individual imputed data sets
FIGURE 1 Flow diagram
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were summarized by an automatic SPSS feature, relying on
Rubin's rule.
All models were evaluated in two different subgroups.
First, according to resection type (unilateral type III or bilat-
eral type II resections) and second according to re-
section involvement of the AC (no involvement, unilateral
involvement, or bilateral involvement).
3 | RESULTS
3.1 | Patients
In total 175 patients with suspected or proven extended T1 and
limited T2 glottic carcinoma were identified as possible candi-
dates for the study between December 2009 and March 2015.
Of these, 89 patients fitted the inclusion criteria during endos-
copy. Of these, 13 patients were lost-to-follow-up or discontin-
ued participation in the first 3 months of the study. Two
patients died due to unrelated causes (1 patient died of urinary
bladder cancer and 1 of cardiovascular disease) and 10 patients
had a recurrent glottic carcinoma before 1 year of follow-up
was completed and were therefore excluded, leaving 64 patients
for analysis (Figure 1).
Of the five outcome measures (G-score, VHI, fundamental
frequency, range SPL, and s/z ratio) 17.2%-26.6% were miss-
ing. Therefore, we performed multiple imputations. Sensitivity
analysis showed that our results were robust (see statistical
methods). For example, the regression coefficients for complete
cases and multiple imputation analysis for the VHI and s/z ratio
respectively were comparable (β VHI 25.8 [SE 4.9] and 25.8
[SE 8.0]; β s/z ratio 1.24 [SE 0.19] and 1.27 [SE 0.19]).
Table 1 shows the baseline characteristics of 64 analyzed
patients. In the overall group, outcomes were not signifi-
cantly affected by the variables age, sex, and T classification
and these were therefore not considered in further analyses.
Table 2 shows voice outcome according to ELS-resection
type and Table 3 shows the results according to the re-
section involvement of the AC.
The 1-year overall recurrence rate was 11.2% (10 out of
89 patients, T1 = 4, T2 = 6). All recurrences occurred in the
unilateral type III resection group (eight patients with and
two without AC involvement).
3.2 | Subjective evaluation
3.2.1 | Perceptual evaluation
The G-score improved in all study groups with mean postop-
erative G-scores varying from 1.49 to 1.15 (unilateral type
III) and from 1.66 to 1.55 (bilateral type II), corresponding
to mild to moderate dysphonia (Table 2). These postopera-
tive G-scores were significantly lower in patients treated
with type III resections compared to bilateral type II resec-
tion. There was no difference in postoperative scores in the
subcategories regarding the AC involvement (Table 3).
Looking at the preoperative to postoperative decrease in G-
score, this was significant in patients treated with a unilateral
type III resection and resections without AC involvement. In
total, more patients presented with a normal or mildly dys-
phonic voice postoperatively (67.2%) than preoperatively
(51.6%) (Figure 2) although this difference was not signifi-
cant. Conversely, 7.8% of patients were rated as severely
dysphonic after surgery.
3.2.2 | Patient self-assessment
The mean VHI scores improved in all study groups postop-
eratively. For the unilateral type III resections, the mean
dropped from 31.8 to 23.3 points. For the bilateral type II
resections, VHI scores decreased from 28.2 to 24.5 points
(Table 2). The improvement in the VHI score was significant
in unilateral type III resections and in resections not involv-
ing the AC (Tables 2 and 3). Looking at individual patients,
23 (35.9%) had a clinically relevant improvement of
10 points or more and 13 (20.3%) had a clinically relevant
deterioration of 10 points or more. This ratio of improve-
ment/deterioration was similar in the five subgroups (unilat-
eral type III, bilateral type II, without AC involvement, or
with unilateral/bilateral involvement). Figure 3 shows the
categorized VHI scores. Postoperatively, more patients
(70.3%, n = 45) experienced less impairment of their voice
than preoperatively (54.7%, n = 35). This difference was not
statistically significant.
3.3 | Objective voice evaluation
3.3.1 | Acoustic evaluation
Range SPL increased in all study groups after treatment with
scores varying from 30.4 to 38.6 dB (Tables 2 and 3). The
increase in range SPL was significant in patients treated with
TABLE 1 Baseline characteristics
Characteristics
No. of patients (%)
Total = 64 (100%)
Mean age at surgery (SD) 67.4 (9.2)
Sex
Male 54 (84.4)
Female 10 (15.6)
T classification
T1a 29 (45.3)
T1b 20 (31.3)
T2 15 (23.4)
ELS resection
Type III 40 (62.5)
Type II bilateral 24 (37.5)
AC involvement
No 13 (20.3)
Unilateral 27 (42.2)
Bilateral 24 (37.5)
Abbreviations: AC, anterior commissure; ELS, European Laryngological Soci-
ety; T, tumor.
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bilateral type II (from 30.5 to 37.1 dB) and resections with
bilateral involvement of the AC (from 31.0 to 36.7 dB)
(Tables 2 and 3). However, there was no statistical differ-
ence between the various groups in the postoperative scores.
The mean speaking fundamental frequency increased for
most patients except for male patients with resections with-
out involvement of the AC and female patients with
resections with bilateral involvement of the AC. The average
postoperative mean speaking fundamental frequency in
males ranged from 131 Hz (resections with unilateral AC
involvement) to 155 Hz (resections without involvement of
the AC) and from 170 Hz (unilateral type III) to 178 Hz
(bilateral type II) in females. The increase in mean speaking
fundamental frequency was significant only in unilateral
TABLE 2 Voice outcome according the type of resection
Preoperative Mean (SD) 1-year post-TLM Mean (SD) Mean difference (95% CI) P-value
ELS type III (no. of patients = 40)
s/z ratio 1.13 (0.38) 1.26 (0.48) −0.13 (−0.31; 0.04) .13
F0 (Hz) male (34) 140 (29) 142 (29) −2 (−14; 10) .72
F0 (Hz) female (6) 170 (51) 187 (55) −17 (−39; 5) .12
Range SPL (dB) 36.7 (13.3) 38.0 (9.67) −1.32 (−4.93; 2.30) .47
VHI 31.8 (17.1) 23.3 (15.3) 8.47 (2.59; 14.34) .005*
G 1.49 (0.77) 1.15 (0.70) 0.35 (0.04; 0.67) .02*
Bilateral type II (no. of patients = 24)
s/z ratio 1.20 (0.48) 0.98 (0.38) 0.22 (0.06; 0.38) .009*
F0 (Hz) male (20) 143 (45) 158 (42) −15 (−31; 1) .06
F0 (Hz) female (4) 178 (45) 183 (42) −5 (−40; 30) .78
Range SPL (dB) 30.5 (13.7) 37.1 (7.4) −6.60 (−11.16; −2.05) .005*
VHI 28.2 (19.8) 24.5 (21.9) 3.70 (−6.23; 13.63) .46
G 1.66 (0.88) 1.55 (0.85) 0.10 (−0.27; 0.48) .59
Abbreviations: dB, decibel; ELS, European Laryngological Society; F0, mean speaking fundamental frequency; G, grade from the GRBAS-rating scale; Hz, Hertz; range
SPL, range sound pressure level; TLM, transoral CO2 laser microsurgery; VHI, voice handicap index.
*Statistically significant (P < .05).
TABLE 3 Voice outcome according to the resection involvement of the anterior commissure
Preoperative
Mean
(SD)
1-year
post-TLM
Mean (SD)
Mean
difference
(95% CI) P-value
Without AC involvement (no. of patients = 13)
s/z ratio 1.17 (0.38) 1.39 (0.51) 0.22 (−0.47; 0.03) .08
F0 (Hz) male (10) 155 (39) 136 (33) 19 (−8; 46) .16
F0 (Hz) female (3) 174 (19) 191 (28) −17 (−49; 15) .29
Range SPL (dB) 35.0 (16.7) 38.6 (10.1) −3.55 (−10.7; 3.60) .33
VHI 33.9 (18.3) 22.3 (14.9) 11.6 (2.15; 21.1) .01*
G 1.68 (0.77) 1.13 (0.58) 0.56 (0.03; 1.08) .4*
With AC involvement unilateral (no. of patients = 27)
s/z ratio 1.12 (0.37) 1.21 (0.44) −0.09 (−0.31; 0.13) .43
F0 (Hz) male (23) 131 (20) 144 (28) −13 (−23; −2) .02*
F0 (Hz) female (4) 172 (64) 191 (68) −19 (−41; 1) .06
Range SPL (dB) 37.0 (11.4) 38.1 (9.6) −1.01 (−4.95; 2.92) .61
VHI 30.4 (17.0) 24.1 (15.3) 6.28 (−1.08; 13.6) .09
G 1.41 (0.76) 1.15 (0.75) 0.26 (−0.14; 0.65) .20
With AC involvement bilateral (no. of patients = 24)
s/z ratio 1.19 (0.48) 0.98 (0.38) 0.22 (0.05; 0.38) .01*
F0 (Hz) male (21) 145 (45) 158 (41) −13 (−29; 3) .10
F0 (Hz) female (3) 175 (20) 172 (32) 3 (−41; 46) .90
Range SPL (dB) 31.0 (14.2) 36.7 (7.40) −5.73 (−10.7; −0.78) .02*
VHI 28.7 (19.6) 24.2 (22.2) 4.45 (−5.65; 14.6) .38
G 1.66 (0.88) 1.55 (0.85) 0.10 (−0.27; 0.48) .59
Abbreviations: AC, anterior commissure; dB, decibel; ELS, European Laryngological Society; F0, mean speaking fundamental frequency; G, grade from the
GRBAS-rating scale; Hz, Hertz; range SPL, range sound pressure level; TLM, transoral CO2 laser microsurgery; VHI, voice handicap index.
*Statistically significant (P < .05).
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resections with involvement of the AC in male patients
(P = .02) (Table 3).
3.3.2 | Aerodynamic evaluation
In the aerodynamic parameter (s/z ratio) we found varying
changes. In some subgroups, the ratio changed toward the ideal
of 1 and in other sub groups, it changed away from this value.
Postoperatively, the s/z ratio was 0.98 compared to 1.2 preoper-
atively (bilateral type II resections and resections with bilateral
AC involvement) and from 1.39 postoperatively compared to
1.17 preoperatively (resections without AC involvement)
(Tables 2 and 3). The s/z ratio showed significant improvement
in patients treated with bilateral type II resections and bilateral
resections of the AC (Tables 2 and 3). Also, postoperative
results of patients treated with bilateral type II resections were
significantly better than patients treated with unilateral type III
resections. Results of patients treated with bilateral resections
of the AC were significantly better than patients treated without
or with a unilateral resection of the AC.
4 | DISCUSSION
In this study, we investigated voice outcome 1 year after treat-
ment in patients with early glottic carcinoma (extended T1 and
limited T2) treated with a unilateral transmuscular (type III) or
bilateral subligamental (bilateral type II) resection. We also
examined the results according to the involvement of the AC in
the resection. For all resection subgroups, most voice parame-
ters show an improvement of the mean score at 1 year postop-
eratively. This means that the defect and fibrosis from surgery
are on average less of a problem for patients than the tumor
itself. As for the postoperative outcome, perceptive dysphonia
is mild but is statistically less after a unilateral type III re-
section (mild) than after a bilateral type II resection (mild to
moderate). The voice handicap is universally low and similar
for all treatment groups, not exceeding a mean of 24.5 out of a
possible 120 points. The dynamic range of patient's voices is
similar for all resection types in which values can be considered
to be in the low normal to slightly decreased range depending
on the reference used for normal values.31,32 The mean speak-
ing fundamental frequency after treatment increases and is
higher than normal for all resection types in male patients but
within normal values for female patients.33 Finally, the effect
on aerodynamic efficiency of voicing varies. In our series,
according to the s/z ratio, voicing is ultimately more efficient in
patients treated with bilateral type II resections and bilateral
resections of the AC than in patients treated with a unilateral
type III resection with or without a unilateral resection of the
AC. It is not clear if this change was also clinically relevant to
the patients as it does not translate into less perceptive dyspho-
nia, larger dynamic range, or lower voice handicap in these
patients. Although mean values for almost all parameters
improve, it is important to realize that this is for group aver-
ages. This means that there is still a group of patients that expe-
rience a decline in voice outcome scores. Although not always
statistically significant, this tends to be male patients with T1b
tumors including the AC.
Interestingly, for the subjective parameters (G-score and
VHI), the improvements that were statistically significant
tended to be in the unilateral type III resections and resec-
tions not involving the AC, whereas statistically significant
improvements in the objective parameters, if present, were
found in the bilateral type II resections and resections
involving the AC. This leads us to conclude—as has been
done previously in literature—that these parameters all high-
light different aspects of voice quality and function and that
improvement in one parameter does not necessarily lead to
improvement in another.34,35
In this study, voice outcome of resections involving the AC
(unilateral or bilateral) did not differ significantly from that of
resections without involvement of the AC in any of the evalu-
ated parameters, except for the s/z ratio. The s/z ratio was sig-
nificantly different (and closer to 1) for patients having
undergone a bilateral resection of the AC versus patients with
resections with no AC involvement (s/z ratio 0.98 vs 1.39).
Therefore, we do not consider involvement of the AC as a neg-
ative factor in this study and our results show acceptable voice
outcome for these resections with mild to moderate dysphonia
and a low VHI. However, it must be emphasized that the resec-
tions involving the AC were of limited extent and depth. The
bilateral resections were subligamental and 58.3% (n = 14)
were performed staged in time. Unfortunately, to the best of
our knowledge, there is no specific literature on functional out-
come of superficial bilateral resections and therefore comparing
FIGURE 2 Distribution of the grade according to the type of resection
FIGURE 3 Distribution of the voice handicap index (VHI) according to
the type of resection
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our results with previous findings was not possible. We would
therefore advocate more publications on data of superficial
bilateral resections.
Our recurrence rate at 1-year was 11.2%. This cannot be
compared directly to recurrence rates reported by other authors
as the mean follow-up time in most studies is longer than in
our study. However, as we expect most of the recurrences to
occur within the first year and as our outcome at this point
compares favorably to local control rates reported for T1 (85%-
87%)21 and T2a (80%)36 in large series, we anticipate that our
eventual results will be in line with literature even though addi-
tional recurrences in the following years of follow-up are possi-
ble. It is important to acknowledge that TLM for T1 and
limited T2 glottic carcinoma is based on the concept of narrow-
margin surgery and that there is ultimately a trade-off between
achieving a radical resection either during the primary re-
section or by means of re-resection of positive margins and
optimizing functional results. There is as of yet no definite rec-
ommendation regarding what constitutes a safe margin.
Recommended resection margins vary between 0.5 and
2 mm21 and both wait-and-see and re-resection regimes are
advocated in literature.37
4.1 | Review literature
The findings on functional outcomes in literature in relation
to our own results are discussed per parameter below.
4.1.1 | Perceptual evaluation
The G-score improved in all subgroups with postoperative
scores varying from light to very moderate dysphonia. The
improvement was significant in patients treated with unilat-
eral type III resections and patients treated without a
resection of the AC. In total, 70.4% of the voices in our
study were rated as a normal or mildly dysphonic after treat-
ment. Vilaseca et al17 found that after type II and III resec-
tions, 55% of their patients had a normal or mildly
dysphonic voice. In line with these results, a study by Cze-
cior et al38 found that in 33 patients, 54% had a normal or
mildly dysphonic voice after type III resection .
Regarding the ELS-resection types, the postoperative
G-score was significantly better in patients with unilateral type
III resections than in patients with bilateral type II resections
although there is no generally accepted value for what makes
up a clinically relevant difference in G-score. Only a few stud-
ies have presented results specifically for patients treated with a
unilateral type III resection. The study by Ledda et al14 ana-
lyzed vocal outcomes of 141 patients with early glottic cancer
after TLM. Thirty of them had a unilateral type III
resection with an overall Grade of 1.29.14 The study by Peretti
et al assessed vocal outcomes in relation to the types of endo-
scopic cordectomy. In their study, 11 patients with early glottic
cancer had a type III resection and scored a G-score of 1.4.13
Our results show a slightly lower G-score of 1.15 postoperative
for patients treated with type III resections. To the best of our
knowledge, no other studies described voice outcome results
for bilateral type II resections.
Regarding the AC involvement, the postoperative G-scores
for resections without involvement of the AC were very simi-
lar to those for resections with one-sided involvement of the
AC. The G-score for resections with bilateral involvement of
the AC was higher although the difference between the three
was not statistically significant. This is in line with our clinical
observations that one-sided resections of the AC have rela-
tively little additional impact on dysphonia compared to resec-
tions not involving the AC. In contrast, most studies show that
resections involving the AC result in worse voice outcome
with regard to the grade of dysphonia than resection without
the AC.16,20,39 This may be caused by the formation of an
anterior glottic scar web in some cases, but also by an
increased glottal gap.7,40 An explanation for this result could
be the fact that the lesions, and therefore the depth of the bilat-
eral resections in our study, were limited as well as the fact
that the resections were staged in 14 patients. This has less
effect on the glottic closure or the development of anterior
glottic scars than in deeper bilateral (type V-VI) resections.
4.1.2 | Patients self-assessment
In line with the G-score, the VHI also improved with a mean
of 3.7-11.6 points in all subgroups with postoperative scores
varying between just 23.3 and 24.5 points. Again, the improve-
ment was significant in patients treated with unilateral type III
resections and patients treated without a resection of the
AC. Looking at individual patients, we found the improvement
to be 10 points or more in 23 patients (35.9%). Conversely, in
13 patients (20.3%), we saw a deterioration of 10 points or
more. Van Gogh et al defined a clinical relevant difference
score to be 10 points in individual patients and 15 points or
more when comparing groups of patients.28 Therefore, we con-
clude that one-third of patients can expect a clinically relevant
improvement in their voice handicap, a little less than half can
expect a similar voice handicap and a minority of one-fifth will
report a clinically relevant deterioration in their voice handicap
1 year postoperatively. These proportions were similar in the
various resection subtypes.
Regarding the ELS-resection type subgroups, the postoper-
ative VHI scores were very similar in both subgroups. Litera-
ture has already shown that unilateral superficial type I-II
resection can provide near to normal VHI scores ranging from
9.0 to 20.7 points.13,16,18,35,41–46 However, the depth of muscle
resection in a type III resection varies according to the depth of
the tumor, and in the case of deeper excisions a type III
resection may induce lasting dysphonia.7 Only a few studies
have investigated the VHI results in unilateral type III resec-
tions specifically as opposed to combining them with other
resection types. Nunez Batalla et al46 investigated the VHI
results in 19 patients with T1a tumors after a unilateral type III
resection and found a mean VHI score of 28.8 points.46 How-
ever, their study design was cross-sectional, meaning that
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patients were not all assessed at the same time-point postsur-
gery although there was a minimal follow-up time of 6 months.
Therefore, comparison with our study is difficult. Fink et al18
assessed 12 patients with early glottic carcinoma and found an
improvement of 16.6 points with a mean VHI score of 27.8
(SD 20.4) points after a median of 7 months. The difference of
16.6 points in this case could be classified as clinically relevant.
For our unilateral type III resections, we found a postoperative
VHI of 23.3. This is slightly lower than in the studies above.
This is in line with the slightly lower G-scores compared to lit-
erature that we found in the perceptual analysis. Both may be
explained by a statistical variation due to the larger size of our
cohort or by a different case-mix with regard to the depth of
the type III resection.
Regarding the AC involvement, again the VHI score was
very similar in the three subgroups. In literature, as with the
dysphonia grade score, involvement of the AC is generally
associated with poorer voice outcomes in the VHI,47
although the number of studies investigating postoperative
outcomes with VHI is limited.20 The study by Taylor
et al investigated functional outcomes of T1b tumors after
TLM with the VHI-10 and without describing the ELS clas-
sification of the resections.47 Therefore, these results are not
directly comparable with our study. The study by Lee
et al compared voice outcomes according to the extent of
surgery (type I-V) and made a distinction between AC
involvement or no involvement. Nineteen patients with
involvement of the AC or who had bilateral vocal cord
involvement revealed a tendency to or had deteriorated voice
quality postoperatively. These VHI scores (47.70 SD 14.90)
are much higher than in our study. Although they combined
the different resection types (type I-V) in analysis, it is prob-
able that the majority of these resections were deeper than in
our series.41 To the best of our knowledge, no study has pre-
sented voice outcome specifically for AC involvement in
either unilateral type III or bilateral type II resections.
4.1.3 | Objective evaluation
Acoustic parameters
The range SPL improved in all subgroups with values that
can be considered within the normal range.32 The improve-
ment was significant in patients with a bilateral type II
resection and in patients with bilateral resections of the
AC. The fact that all patients showed a trend toward postop-
erative improvement of the range SPL means that they had a
wider range between the softest and loudest voicing after
treatment. Functionally, this leads to more dynamic possibil-
ities resulting in a larger range in loudness of speech. In line
with our results, the study by Jotic et al showed a significant
improvement of range SPL for 19 patients with early glottic
carcinoma (Tis-T1) treated with type II-IV resections.48 This
suggests that on average in these patients, the tumor itself is
more restrictive for dynamic range than the loss of tissue
and fibrosis following the resection. The reason why the
change in range SPL was larger and statistically significant
in bilateral type II resections is presumably because these
patients had a lower range SPL before treatment, due to the
tumor on both vocal folds, resulting in worse vibration of
the vocal folds preoperatively than in patients with unilateral
lesions. However, improvement in range SPL may only be
noticeable for the patients themselves, because changes
between 3.3 and 6.6 dB as in this study are hard to distin-
guish for listeners. It is likely that patients will notice that
less energy is needed to produce a softer or louder voice.
The mean speaking fundamental frequency increased for
most patient groups. For males, the postoperative scores
were all outside the range for normal values (100-130 Hz)24
and was the highest in patients with a bilateral type II re-
section and patients with resections that involved the AC
bilaterally. Voices of males having undergone unilateral type
III resections, and resections with no or only unilateral
involvement of the AC tended to have slightly lower postop-
erative fundamental frequency. For females, all mean post-
operative frequencies were within the normal range
(160-230 Hz)24 and would not be remarkable in daily com-
munication. The mean speaking fundamental frequency is
influenced by the length, size, and tension of the vocal folds.
After TLM, the vocal fold has a lower mass and is generally
stiffer due to loss of the lamina propria and the introduction
of fibrosis leading to higher fundamental frequency.47–49
Other studies have also shown an increase in fundamental
frequency after treatment with TLM.2,50,51 Our results are in
line with this theoretical explanation as well as with the find-
ing in other studies. We have no explanation for the fact that
the fundamental frequency decreased in two of our subpopu-
lations above and believe this to be coincidental variation.
Aerodynamic parameters
The effect on aerodynamic efficiency of voicing in our
study varied. In unilateral type III resections and resec-
tions not involving or with only one-sided involvement of
the AC the s/z ratio increased, moving away from the
ideal value of 1. In bilateral type II resections and resec-
tions with bilateral involvement of the AC, the s/z ratio
decreased and moved closer to the ideal value of 1. The
preoperative and postoperative difference was significant
in this latter group. This implies a higher voice efficiency
was obtained after bilateral type II resections even if these
lesions involved the AC. This means that after the resec-
tion, there was less air leakage or less energy was needed
in order to produce vibration of the vocal folds than in
patients with unilateral, though deeper, resections. Normal
speaking subjects (with no deficits of the vocal folds) are
able to sustain the /s/ and /z/ for about the same length of
time, resulting in a s/z ratio of around 1.0. In the study by
Eckel and Boone, patients with laryngeal pathology pro-
duced a mean s/z ratio of 1.4 in 95% of the time.52 In
accordance with this study, our results showed a s/z ratio
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between 1.0 and 1.4 for all patients after treatment. For
this aerodynamic parameter, we only found one compara-
ble study, from Luo et al51 performed in Taiwan. They
evaluated the long-term voice characteristics and quality
of life in 18 patients with early glottic cancer (Tis-T2)
treated with TLM. The s/z ratio that they found after treat-
ment (1.08) is comparable with our results.51 Although we
found one study to compare our results with, the s/z ratio
is still a difficult parameter to interpret. In our study, we
were not able to detect a certain pattern in this parameter.
4.2 | Limitations
There are several limitations of this study. First, due to the
longitudinal study design and the inclusion of patients in
three different hospitals, we were not able to prevent the
occurrence of missing data even though this was a pro-
spective study. Therefore, we performed multiple imputa-
tion to maximize our use of the data and mitigate the
problem of selective missingness. This method is an
accepted and flexible method to deal with missing data,
when multiple variables have missing values and observed
data contains information on missing values.53 Second,
we used the s/z ratio as an aerodynamic parameter in our
study. The fact that we found no clear trend in our out-
come coupled with the fact that this parameter is not com-
monly used in this population makes it difficult to
interpret our results. We would therefore consider using a
different aerodynamic parameter in further studies. Third,
the subgroups regarding the ELS classification and the
AC involvement were of unequal size. According to the
AC involvement, 27, patients had a unilateral and 24 a
bilateral resection involving the AC as opposed to 13 with-
out. This difference in group size may have affected the
outcomes of our study. This is of particular note as con-
trary to most studies, we did not find that involvement of
the AC affected the voice outcome. However, we believe
that this is mainly due to the limited size of the resections
and not to a statistical flaw. Finally, a common problem in
voice research is the large variety of voice tests used
within the different dimensions of voice analysis and the
lack of standardization of data collection, especially in
objective evaluation (aerodynamic and acoustic).
5 | CONCLUSION
On average, the voice in patients treated for early glottic car-
cinoma (extended T1 and limited T2) with unilateral trans-
muscular (type III) or bilateral subligamental (type II)
resections can be expected to have mild to very moderate
dysphonia 1 year postoperatively as rated by experienced lis-
teners and by patients' self-assessment. Dynamic range will
be in the low normal to slightly decreased range and funda-
mental frequency will be higher than normal in male but not
in female patients. Compared to preoperatively, the majority
of patients can expect an improvement in their voice parame-
ters translating to a clinically relevant improvement in voice
handicap (VHI) in a third (36%) or a similar degree of voice
handicap in almost half (46%) of patients 1 year postopera-
tively. A minority of patients (20%) will report a clinically
relevant increase in voice handicap. These aforementioned
findings are in line with current literature and are important
to incorporate into discussion with patients during counsel-
ing for treatment options. We consider these results to be
functionally acceptable and TLM to be a valid option in
these patients from a functional standpoint.
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